Clinical Trial Update: Cardiovascular and Torsades de Pointes Monitoring for Pazopanib

View source ↗

Summary

This clinical trial update reviews cardiovascular safety monitoring for pazopanib, including Torsades de Pointes risk. It pertains to patients with renal cell c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Votrient (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Carcinoma, Renal Cell | Status: COMPLETED